Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.

Sanford NN, Sher DJ, Butler S, Xu X, Ahn C, D'Amico AV, Rebbeck T, Aizer AA, Mahal BA.

JAMA Netw Open. 2019 May 3;2(5):e193759. doi: 10.1001/jamanetworkopen.2019.3759.

2.

Self-reported Reasons and Patterns of Noninsurance Among Cancer Survivors Before and After Implementation of the Affordable Care Act, 2000-2017.

Sanford NN, Lam MB, Butler SS, Ahn C, Beg MS, Aizer AA, Mahal BA.

JAMA Oncol. 2019 May 15:e191973. doi: 10.1001/jamaoncol.2019.1973. [Epub ahead of print]

PMID:
31091534
3.

Survival and prognostic factors in surgically treated brain metastases.

Kavouridis VK, Harary M, Hulsbergen AFC, Lo YT, Reardon DA, Aizer AA, Iorgulescu JB, Smith TR.

J Neurooncol. 2019 Jun;143(2):359-367. doi: 10.1007/s11060-019-03171-6. Epub 2019 Apr 16.

PMID:
30989623
4.

Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases.

Cagney DN, Lamba N, Montoya S, Li P, Besse L, Martin AM, Brigell RH, Catalano PJ, Brown PD, Leone JP, Tanguturi SK, Haas-Kogan DA, Alexander BM, Lin NU, Aizer AA.

Breast Cancer Res Treat. 2019 Jul;176(1):171-179. doi: 10.1007/s10549-019-05236-6. Epub 2019 Apr 13.

PMID:
30982195
5.

Prevalence and Nondisclosure of Complementary and Alternative Medicine Use in Patients With Cancer and Cancer Survivors in the United States.

Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA.

JAMA Oncol. 2019 Apr 11. doi: 10.1001/jamaoncol.2019.0349. [Epub ahead of print] No abstract available.

PMID:
30973579
6.

Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases.

Cagney DN, Lamba N, Sinha S, Catalano PJ, Bi WL, Alexander BM, Aizer AA.

JAMA Oncol. 2019 Mar 7. doi: 10.1001/jamaoncol.2018.7204. [Epub ahead of print]

PMID:
30844036
7.

Trends in Smoking and e-Cigarette Use Among US Patients With Cancer, 2014-2017.

Sanford NN, Sher DJ, Xu X, Aizer AA, Mahal BA.

JAMA Oncol. 2019 Feb 14. doi: 10.1001/jamaoncol.2018.6858. [Epub ahead of print] No abstract available.

PMID:
30763430
8.

Local control after brain-directed radiation in patients with cystic versus solid brain metastases.

Brigell RH, Cagney DN, Martin AM, Besse LA, Catalano PJ, Lee EQ, Wen PY, Brown PD, Phillips JG, Pashtan IM, Tanguturi SK, Haas-Kogan DA, Alexander BM, Aizer AA.

J Neurooncol. 2019 Apr;142(2):355-363. doi: 10.1007/s11060-019-03106-1. Epub 2019 Feb 4.

PMID:
30715665
9.

A low percentage of metastases in deep brain and temporal lobe structures.

Yanagihara TK, McFaline-Figueroa JR, Giacalone NJ, Lee AW, Soni V, Hwang ME, Hsieh KT, Saraf A, Wu CC, Yang D, Wen PY, Ashamalla H, Aizer AA, Wang TJC, Huang RY.

Neuro Oncol. 2019 May 6;21(5):640-647. doi: 10.1093/neuonc/noz023.

PMID:
30715520
10.

The Misclassification of Diffuse Gliomas: Rates and Outcomes.

Iorgulescu JB, Torre M, Harary M, Smith TR, Aizer AA, Reardon DA, Barnholtz-Sloan JS, Perry A.

Clin Cancer Res. 2019 Apr 15;25(8):2656-2663. doi: 10.1158/1078-0432.CCR-18-3101. Epub 2019 Jan 11.

PMID:
30635340
11.

Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis.

Lamba N, Cagney DN, Brigell RH, Martin AM, Besse LA, Catalano PJ, Phillips JG, Pashtan IM, Bi WL, Claus EB, Golby AJ, Dunn IF, Smith TR, Tanguturi SK, Haas-Kogan DA, Alexander BM, Aizer AA.

World Neurosurg. 2019 Feb;122:e1557-e1561. doi: 10.1016/j.wneu.2018.11.100. Epub 2018 Nov 22.

PMID:
30471438
12.

The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.

Pike LRG, Bang A, Mahal BA, Taylor A, Krishnan M, Spektor A, Cagney DN, Aizer AA, Alexander BM, Rahma O, Balboni T, Ott PA, Hodi FS, Schoenfeld JD.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):142-151. doi: 10.1016/j.ijrobp.2018.09.010. Epub 2018 Sep 15.

PMID:
30227198
13.

Brain Metastases.

Aizer AA, Lee EQ.

Neurol Clin. 2018 Aug;36(3):557-577. doi: 10.1016/j.ncl.2018.04.010. Epub 2018 Jun 18. Review.

PMID:
30072071
14.

Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort.

Iorgulescu JB, Harary M, Zogg CK, Ligon KL, Reardon DA, Hodi FS, Aizer AA, Smith TR.

Cancer Immunol Res. 2018 Sep;6(9):1039-1045. doi: 10.1158/2326-6066.CIR-18-0067. Epub 2018 Jul 12.

PMID:
30002157
15.

Implications of Screening for Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer.

Cagney DN, Martin AM, Catalano PJ, Brown PD, Alexander BM, Lin NU, Aizer AA.

JAMA Oncol. 2018 Jul 1;4(7):1001-1003. doi: 10.1001/jamaoncol.2018.0813. No abstract available.

16.

Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce.

Dinh KT, Aizer AA, Muralidhar V, Mahal BA, Chen YW, Beard CJ, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL.

Am J Med. 2018 May;131(5):517-523. doi: 10.1016/j.amjmed.2017.11.039. Epub 2018 Mar 16.

PMID:
29555248
17.

Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.

Sanford NN, Martin AM, Brunner AM, Cote GM, Choy E, DeLaney TF, Aizer AA, Chen YL.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):687-694. doi: 10.1016/j.ijrobp.2017.11.011. Epub 2017 Nov 14.

PMID:
29413281
18.

Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.

Cagney DN, Martin AM, Catalano PJ, Reitman ZJ, Mezochow GA, Lee EQ, Wen PY, Weiss SE, Brown PD, Ahluwalia MS, Arvold ND, Tanguturi SK, Haas-Kogan DA, Alexander BM, Redig AJ, Aizer AA.

Radiother Oncol. 2018 Mar;126(3):511-518. doi: 10.1016/j.radonc.2018.01.005. Epub 2018 Feb 3.

PMID:
29398153
19.

Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.

Martin AM, Cagney DN, Catalano PJ, Alexander BM, Redig AJ, Schoenfeld JD, Aizer AA.

JAMA Oncol. 2018 Aug 1;4(8):1123-1124. doi: 10.1001/jamaoncol.2017.3993. No abstract available.

20.

The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.

Sun M, De Velasco G, Brastianos PK, Aizer AA, Martin A, Moreira R, Nguyen PL, Trinh QD, Choueiri TK.

Eur Urol Focus. 2018 Jan 5. pii: S2405-4569(17)30294-8. doi: 10.1016/j.euf.2017.12.007. [Epub ahead of print]

PMID:
29311016
21.

Non-tunneled versus tunneled dialysis catheters for acute kidney injury requiring renal replacement therapy: a prospective cohort study.

Mendu ML, May MF, Kaze AD, Graham DA, Cui S, Chen ME, Shin N, Aizer AA, Waikar SS.

BMC Nephrol. 2017 Dec 4;18(1):351. doi: 10.1186/s12882-017-0760-x.

22.

Radiographic prediction of meningioma grade by semantic and radiomic features.

Coroller TP, Bi WL, Huynh E, Abedalthagafi M, Aizer AA, Greenwald NF, Parmar C, Narayan V, Wu WW, Miranda de Moura S, Gupta S, Beroukhim R, Wen PY, Al-Mefty O, Dunn IF, Santagata S, Alexander BM, Huang RY, Aerts HJWL.

PLoS One. 2017 Nov 16;12(11):e0187908. doi: 10.1371/journal.pone.0187908. eCollection 2017.

23.

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.

Arvold ND, Shi DD, Aizer AA, Norden AD, Reardon DA, Lee EQ, Nayak L, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Wen PY, Alexander BM.

J Neurooncol. 2017 Dec;135(3):581-591. doi: 10.1007/s11060-017-2611-9. Epub 2017 Oct 3.

PMID:
28975467
24.

Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.

Churilla TM, Handorf E, Collette S, Collette L, Dong Y, Aizer AA, Kocher M, Soffietti R, Alexander BM, Weiss SE.

Ann Oncol. 2017 Oct 1;28(10):2588-2594. doi: 10.1093/annonc/mdx332.

25.

Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer.

Aizer AA, Mak R, Alexander BM.

Neuro Oncol. 2017 Aug 1;19(8):1015-1016. doi: 10.1093/neuonc/nox113. No abstract available.

26.

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation.

Pike LRG, Bang A, Ott P, Balboni T, Taylor A, Catalano P, Rawal B, Spektor A, Krishnan M, Cagney D, Alexander B, Aizer AA, Buchbinder E, Awad M, Gandhi L, Hodi FS, Schoenfeld JD.

Radiother Oncol. 2017 Jul;124(1):98-103. doi: 10.1016/j.radonc.2017.06.006. Epub 2017 Jun 26.

PMID:
28662869
27.

Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

Cagney DN, Alexander BM, Hodi FS, Buchbinder EI, Ott PA, Aizer AA.

J Neurooncol. 2017 May;133(1):221. doi: 10.1007/s11060-017-2485-x. No abstract available.

PMID:
28527005
28.

Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.

Bang A, Wilhite TJ, Pike LRG, Cagney DN, Aizer AA, Taylor A, Spektor A, Krishnan M, Ott PA, Balboni TA, Hodi FS, Schoenfeld JD.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):344-351. doi: 10.1016/j.ijrobp.2017.02.003. Epub 2017 Feb 11.

PMID:
28463153
29.

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Cagney DN, Martin AM, Catalano PJ, Redig AJ, Lin NU, Lee EQ, Wen PY, Dunn IF, Bi WL, Weiss SE, Haas-Kogan DA, Alexander BM, Aizer AA.

Neuro Oncol. 2017 Oct 19;19(11):1511-1521. doi: 10.1093/neuonc/nox077.

30.

Whole brain radiotherapy for non-small cell lung cancer.

Cagney DN, Alexander BM, Aizer AA.

Lancet. 2017 Apr 8;389(10077):1394-1395. doi: 10.1016/S0140-6736(17)30895-4. No abstract available.

PMID:
28402816
31.

Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study.

Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA, Alexander BM, Lin NU, Aizer AA.

JAMA Oncol. 2017 Aug 1;3(8):1069-1077. doi: 10.1001/jamaoncol.2017.0001.

32.

Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

Cagney DN, Alexander BM, Hodi FS, Buchbinder EI, Ott PA, Aizer AA.

J Neurooncol. 2016 Sep;129(3):389-393. doi: 10.1007/s11060-016-2196-8. Epub 2016 Jul 11. Erratum in: J Neurooncol. 2017 May 19;:.

PMID:
27401151
33.

Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.

Inverso G, Mahal BA, Aizer AA, Donoff RB, Chuang SK.

J Oral Maxillofac Surg. 2016 Jun;74(6):1241-7. doi: 10.1016/j.joms.2015.12.023. Epub 2016 Jan 8.

PMID:
26851312
34.

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.

Abedalthagafi M, Bi WL, Aizer AA, Merrill PH, Brewster R, Agarwalla PK, Listewnik ML, Dias-Santagata D, Thorner AR, Van Hummelen P, Brastianos PK, Reardon DA, Wen PY, Al-Mefty O, Ramkissoon SH, Folkerth RD, Ligon KL, Ligon AH, Alexander BM, Dunn IF, Beroukhim R, Santagata S.

Neuro Oncol. 2016 May;18(5):649-55. doi: 10.1093/neuonc/nov316. Epub 2016 Jan 28.

35.

Genomic landscape of intracranial meningiomas.

Bi WL, Abedalthagafi M, Horowitz P, Agarwalla PK, Mei Y, Aizer AA, Brewster R, Dunn GP, Al-Mefty O, Alexander BM, Santagata S, Beroukhim R, Dunn IF.

J Neurosurg. 2016 Sep;125(3):525-35. doi: 10.3171/2015.6.JNS15591. Epub 2016 Jan 15.

PMID:
26771848
36.

Asian Americans and prostate cancer: A nationwide population-based analysis.

Chao GF, Krishna N, Aizer AA, Dalela D, Hanske J, Li H, Meyer CP, Kim SP, Mahal BA, Reznor G, Schmid M, Choueiri TK, Nguyen PL, O'Leary M, Trinh QD.

Urol Oncol. 2016 May;34(5):233.e7-15. doi: 10.1016/j.urolonc.2015.11.013. Epub 2015 Dec 22.

PMID:
26725248
37.

Clinical predictors of diagnostic testing utility in the initial evaluation of chronic kidney disease.

Mendu ML, Lundquist A, Aizer AA, Leaf DE, Robinson E, Steele DJ, Waikar SS.

Nephrology (Carlton). 2016 Oct;21(10):851-9. doi: 10.1111/nep.12676.

38.

Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer.

Mahal BA, Aizer AA, Efstathiou JA, Nguyen PL.

Cancer. 2016 Jan 1;122(1):78-83. doi: 10.1002/cncr.29691. Epub 2015 Sep 15.

39.

A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.

Aizer AA, Abedalthagafi M, Bi WL, Horvath MC, Arvold ND, Al-Mefty O, Lee EQ, Nayak L, Rinne ML, Norden AD, Reardon DA, Wen PY, Ligon KL, Ligon AH, Beroukhim R, Dunn IF, Santagata S, Alexander BM.

Neuro Oncol. 2016 Feb;18(2):269-74. doi: 10.1093/neuonc/nov177. Epub 2015 Aug 30.

40.

Extent of resection and overall survival for patients with atypical and malignant meningioma.

Aizer AA, Bi WL, Kandola MS, Lee EQ, Nayak L, Rinne ML, Norden AD, Beroukhim R, Reardon DA, Wen PY, Al-Mefty O, Arvold ND, Dunn IF, Alexander BM.

Cancer. 2015 Dec 15;121(24):4376-81. doi: 10.1002/cncr.29639. Epub 2015 Aug 26.

41.

Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.

Kang YJ, Bi WL, Dubuc AM, Martineau L, Ligon AH, Berkowitz AL, Aizer AA, Lee EQ, Ligon KL, Ramkissoon SH, Dunn IF.

World Neurosurg. 2016 Jan;85:96-105. doi: 10.1016/j.wneu.2015.07.032. Epub 2015 Jul 28. Review.

PMID:
26226092
42.

Medical androgen deprivation therapy and increased non-cancer mortality in non-metastatic prostate cancer patients aged ≥66 years.

Abdollah F, Sammon JD, Reznor G, Sood A, Schmid M, Klett DE, Sun M, Aizer AA, Choueiri TK, Hu JC, Kim SP, Kibel AS, Nguyen PL, Menon M, Trinh QD.

Eur J Surg Oncol. 2015 Nov;41(11):1529-39. doi: 10.1016/j.ejso.2015.06.011. Epub 2015 Jul 15.

PMID:
26210655
43.

Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases.

Liu Y, Alexander BM, Chen YH, Horvath MC, Aizer AA, Claus EB, Dunn IF, Golby AJ, Johnson MD, Friesen S, Mannarino EG, Wagar M, Hacker FL, Arvold ND.

J Neurooncol. 2015 Sep;124(3):429-37. doi: 10.1007/s11060-015-1855-5. Epub 2015 Jun 25.

PMID:
26108659
44.

Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors.

Aizer AA, Du R, Wen PY, Arvold ND.

J Neurooncol. 2015 Sep;124(2):291-7. doi: 10.1007/s11060-015-1839-5. Epub 2015 Jun 17.

PMID:
26080799
45.

Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.

Arvold ND, Tanguturi SK, Aizer AA, Wen PY, Reardon DA, Lee EQ, Nayak L, Christianson LW, Horvath MC, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Alexander BM.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):384-9. doi: 10.1016/j.ijrobp.2015.01.017. Epub 2015 Apr 1.

PMID:
25841623
46.

Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment.

Trinh QD, Nguyen PL, Leow JJ, Dalela D, Chao GF, Mahal BA, Nayak M, Schmid M, Choueiri TK, Aizer AA.

J Natl Cancer Inst. 2015 Mar 20;107(6):djv054. doi: 10.1093/jnci/djv054. Print 2015 Jun.

PMID:
25794888
47.

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D, Dubuc A, Brown L, Burns M, Cryan JB, Abedalthagafi M, Kang YJ, Schultz N, Reardon DA, Lee EQ, Rinne ML, Norden AD, Nayak L, Ruland S, Doherty LM, LaFrankie DC, Horvath M, Aizer AA, Russo A, Arvold ND, Claus EB, Al-Mefty O, Johnson MD, Golby AJ, Dunn IF, Chiocca EA, Trippa L, Santagata S, Folkerth RD, Kantoff P, Rollins BJ, Lindeman NI, Wen PY, Ligon AH, Beroukhim R, Alexander BM, Ligon KL.

Neuro Oncol. 2015 Oct;17(10):1344-55. doi: 10.1093/neuonc/nov015. Epub 2015 Mar 9.

48.

The usefulness of diagnostic testing in the initial evaluation of chronic kidney disease.

Mendu ML, Lundquist A, Aizer AA, Leaf DE, Robinson E, Steele DJ, Waikar SS.

JAMA Intern Med. 2015 May;175(5):853-6. doi: 10.1001/jamainternmed.2015.17. No abstract available.

49.

Who bears the greatest burden of aggressive treatment of indolent prostate cancer?

Mahal BA, Cooperberg MR, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Orio PF 3rd, Trinh QD, Nguyen PL.

Am J Med. 2015 Jun;128(6):609-16. doi: 10.1016/j.amjmed.2014.12.030. Epub 2015 Jan 30.

50.

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.

Du Z, Abedalthagafi M, Aizer AA, McHenry AR, Sun HH, Bray MA, Viramontes O, Machaidze R, Brastianos PK, Reardon DA, Dunn IF, Freeman GJ, Ligon KL, Carpenter AE, Alexander BM, Agar NY, Rodig SJ, Bradshaw EM, Santagata S.

Oncotarget. 2015 Mar 10;6(7):4704-16.

Supplemental Content

Loading ...
Support Center